Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NQO1 | P15559 | 1/20 | 0.59 |
| ▸ | TTR | P02766 | 4/20 | 0.55 |
| ▸ | ESR2 | Q92731 | 6/20 | 0.50 |
| ▸ | ESR1 | P03372 | 5/20 | 0.50 |
| ▸ | SOS2 | Q07890 | 1/20 | 0.44 |
| ▸ | ESRRB | O95718 | 1/20 | 0.41 |
| ▸ | ESRRA | P11474 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | HSD17B14 | Q9BPX1 | 1/20 | 0.38 |
| ▸ | PFKFB3 | Q16875 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.37 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.37 |
| ▸ | MIF | P14174 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | CTSB | P07858 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11038799 | 0.86 | NQO1 (0.47) | NQO1TTRESR2ESR1SOS2 | |
| SCHEMBL5020158 | 0.77 | NQO1 (0.59) | NQO1TTRSOS2CYP1A2KDM4E | |
| SCHEMBL8002770 | 0.77 | NQO1 (0.64) | NQO1TTRCYP1A2KDM4EALDH1A1 | |
| SCHEMBL12599791 | 0.77 | NQO1 (0.59) | NQO1TTRSOS2CYP1A2KDM4E | |
| SCHEMBL28739915 | 0.77 | NQO1 (0.59) | NQO1TTRSOS2CYP1A2KDM4E | |
| SCHEMBL743391 | 0.77 | NQO1 (0.59) | NQO1SOS2KDM4EPDE3BPDE3A | |
| SCHEMBL906662 | 0.77 | NQO1 (0.59) | NQO1TTRSOS2KDM4EALDH1A1 | |
| SCHEMBL28168936 | 0.77 | NQO1 (0.59) | NQO1TTRSOS2CYP1A2KDM4E | |
| SCHEMBL16936288 | 0.77 | NQO1 (0.54) | NQO1TTRSOS2KDM4EALDH1A1 | |
| SCHEMBL17442633 | 0.77 | NQO1 (0.54) | NQO1TTRSOS2KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2265677-B1 | CORROSION DETECTION PRODUCT AND METHOD | BATTELLE MEMORIAL INSTITUTE (US) | 2019-05-15 | — | — | EP | claimed |
| US-9642922-B2 | Caspase-triggered nano-aggregation probes and methods of use | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2017-05-09 | — | — | US | claimed |
| US-20150056137-A1 | CASPASE-TRIGGERED NANO-AGGREGATION PROBES AND METHODS OF USE | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2015-02-26 | — | — | US | claimed |
| EP-4748400-A1 | CONJUGATE FOR ANTIGEN DELIVERY AND USE THEREOF | LG Chem, Ltd. (KR) | 2026-05-27 | — | — | EP | disclosed |
| EP-4543457-A1 | ENTRY-MODULATING AGENTS AND USES THEREFOR | Griffith University (AU) | 2025-04-30 | — | — | EP | disclosed |
| CN-119386001-A | Pharmaceutical compositions containing PEITC and their use in the treatment of cancer | 无锡杰西医药股份有限公司 | 2025-02-07 | — | — | CN | disclosed |
| WO-2025028960-A1 | CONJUGATE FOR ANTIGEN DELIVERY AND USE THEREOF | 주식회사 엘지화학 | 2025-02-06 | — | — | WO | disclosed |
| US-12012394-B2 | Alpha-synuclein ligands | WASHINGTON UNIVERSITY (US) | 2024-06-18 | — | — | US | disclosed |
| US-20240042068-A1 | CASPASE-3-TRIGGERED MOLECULAR SELF-ASSEMBLING PET PROBES AND USES THEREOF | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2024-02-08 | — | — | US | disclosed |
| WO-2023245258-A1 | ENTRY-MODULATING AGENTS AND USES THEREFOR | GRIFFITH UNIVERSITY (AU) | 2023-12-28 | — | — | WO | disclosed |
| US-20230390268-A1 | METHOD FOR TREATING VIRAL INFECTIONS USING ASK1 INHIBITORS | MCMASTER UNIVERSITY (CA) | 2023-12-07 | — | — | US | disclosed |
| EP-1935986-A2 | Luminogenic and fluorogenic compounds and methods to detect molecules or conditions | PROMEGA CORPORATION (US) | 2008-06-25 | — | — | EP | disclosed |
| EP-1885875-A2 | LUMINOGENIC AND FLUOROGENIC COMPOUNDS AND METHODS TO DETECT MOLECULES OR CONDITIONS | PROMEGA CORPORATION (US) | 2008-02-13 | — | — | EP | disclosed |
| EP-1499319-B1 | BICYCLO 4.4.0 ANTIVIRAL DERIVATIVES | BRISTOL MYERS SQUIBB CO (US) | 2007-12-05 | — | — | EP | disclosed |
| US-20070015790-A1 | Luminogenic and fluorogenic compounds and methods to detect molecules or conditions | JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT | 2007-01-18 | — | — | US | disclosed |
| US-20070015790-A1 | Luminogenic and fluorogenic compounds and methods to detect molecules or conditions | JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT | 2007-01-18 | — | — | US | disclosed |
| US-20070015790-A1 | Luminogenic and fluorogenic compounds and methods to detect molecules or conditions | JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT | 2007-01-18 | — | — | US | disclosed |
| WO-2006130551-A2 | LUMINOGENIC AND FLUOROGENIC COMPOUNDS AND METHODS TO DETECT MOLECULES OR CONDITIONS | PROMEGA CORPORATION (US) | 2006-12-07 | — | — | WO | disclosed |
| EP-0124577-A1 | NEW CHELATE FORMING QUINOLINE COMPOUNDS AND PROCESSES FOR RECOVERING METALS | HÖGBERG, Sverker (SE) | 1984-11-14 | — | — | EP | disclosed |
| WO-1984001947-A1 | NEW CHELATE FORMING QUINOLINE COMPOUNDS AND PROCESSES FOR RECOVERING METALS | HOEGBERG SVERKER | 1984-05-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230390268-A1 | METHOD FOR TREATING VIRAL INFECTIONS USING ASK1 INHIBITORS | IRAK1, EIF2AK2, ZC3HAV1 | NQO1 4277/4885TTR 2578/4885ESR2 3333/4885 |
| US-20150056137-A1 | CASPASE-TRIGGERED NANO-AGGREGATION PROBES AND METHODS OF USE | CASP3, CASP7, CASP2 | NQO1 953/4885TTR 1504/4885ESR2 4295/4885 |
| US-20240042068-A1 | CASPASE-3-TRIGGERED MOLECULAR SELF-ASSEMBLING PET PROBES AND USES THEREOF | CASP3, CASP14, CASP6 | NQO1 3529/4885TTR 2542/4885ESR2 3506/4885 |
| US-12012394-B2 | Alpha-synuclein ligands | SNCA, PARK7, LRRK2 | NQO1 909/4885TTR 747/4885ESR2 3992/4885 |
| US-20070015790-A1 | Luminogenic and fluorogenic compounds and methods to detect molecules or conditions | GLB1, NOD1, PYCARD | NQO1 516/4885TTR 2786/4885ESR2 1953/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.